Humagrip, 12 tablets and 4 capsules, Urgo

Short-term symptomatic treatment of flu-like conditions accompanied by headache and/or fever and a stuffy nose.

Recommended only for adults and children over 15 years of age.

Composition:

• 1 tablet per day contains: paracetamol 500 mg, pseudoephedrine hydrochloride 60 mg and excipients: microcrystalline cellulose, pregelatinized starch, croscarmellose sodium, magnesium stearate, povidone K30
• 1 capsule in the evening a bed contains: paracetamol 500 mg, chlorpheniramine maleate 4 mg and excipients: talc, sodium lauryl sulfate, colloidal anhydrous silicon dioxide, croscarmellose sodium, erythrosine (E127), indigo carmine (E132), titanium dioxide (E171), gelatin
• Active ingredient: carbocisteinum.

How to use:

• The maximum duration is 4 days. An interval of at least 4 hours will be observed between intakes
• The recommended dose is one white tablet daily in the morning and one blue capsule in the evening before bedtime
• If necessary, you can take white tablets at lunchtime and in the evening, but you should not exceed 3 white tablets and one blue capsule per day.

Contraindications:

Do not take HUMAGRIP tablets and capsules

• if you are under 15 years old
• if you are allergic to the active substances or to any of the other ingredients of this medicine
• if you are breastfeeding
• in general, use in pregnant women is not recommended.

Precautions:

Before using HUMAGRIP tablets and capsules, consult your doctor or pharmacist.

Pregnancy, breastfeeding and fertility:

• If you are pregnant or breastfeeding, think you may be pregnant or are planning to become pregnant, ask your doctor or pharmacist for advice before taking this medicine
• Pseudo presence Ephedrine requires avoiding the use of HUMAGRIP during pregnancy
• Experimental and clinical studies conducted on several hundred pregnant women have excluded the malformative effect of pseudoephedrine. Fetal toxicity is related to the pharmacological action of the molecule and can manifest itself with tachycardia and fetal hyperactivity
• Consequently, pseudoephedrine can be prescribed during pregnancy only in case of absolute necessity and only on the advice of a doctor
• It is contraindicated in case of fetal distress or maternal hypertensive pathology
• HUMAGRIP is contraindicated during breastfeeding, since pseudoephedrine is excreted in breast milk and can cause tachycardia in the newborn.

Driving and using machines:

• Drivers and people operating machinery should be warned that HUMAGRIP may cause drowsiness or mild agitation.

Presentation: 12 tablets and 4 capsules